Picture of Biophytis SA logo

ALBPS — Biophytis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Biophytis: New Convertible Bond Financing For Up To EUR 32 Million With Atlas

June 21 (Reuters) - Biophytis  ALBPS.PA :
    * ANNOUNCED ON SATURDAY NEW CONVERTIBLE BOND FINANCING FOR
UP TO
€32 MILLION WITH ATLAS AND DRAWING OF 2 TRANCHES UNDER 2020
ATLAS CONTRACT FOR €6 MILLION
    * THIS LINE OF FINANCING WILL BE USED FOR FURTHER CLINICAL
DEVELOPMENT OF SARCONEOS (BIO101) IN SARCOPENIA FOLLOWING SARA
PHASE 2 RESULTS AND FOR NEXT DEVELOPMENT STEPS OF PRODUCT IN
COVID-19 FOLLOWING COVA PHASE 2-3 RESULTS
    * ISSUANCE OF 240 ORNANE BONDS, FOR A TOTAL AMOUNT OF €6
MILLION
UNDER EXISTING CONVERTIBLE BOND AGREEMENT WITH ATLAS
    * ORNANE WILL HAVE PAR VALUE OF €25 000 EUROS
    * ORNANE WILL NOT BEAR INTEREST AND WILL HAVE 24-MONTH
MATURITY
FROM ISSUANCE

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nNDLqGSpq
    
 Further company coverage:  ALBPS.PA  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Biophytis SA

See all news